Medtronic Balance Sheet Health
Finanzielle Gesundheit Kriterienprüfungen 3/6
Medtronic hat ein Gesamteigenkapital von $50.4B und eine Gesamtverschuldung von $25.0B, wodurch sich der Verschuldungsgrad auf 49.6% beläuft. Die Gesamtaktiva und Gesamtpassiva betragen $90.0B bzw. $39.6B. Medtronic Das EBIT des Unternehmens beträgt $6.5B, so dass der Zinsdeckungsgrad 9 beträgt. Das Unternehmen verfügt über Barmittel und kurzfristige Anlagen in Höhe von $8.0B.
Wichtige Informationen
57.8%
Verhältnis von Schulden zu Eigenkapital
US$27.81b
Verschuldung
Zinsdeckungsgrad | 46.2x |
Bargeld | US$7.84b |
Eigenkapital | US$48.16b |
Gesamtverbindlichkeiten | US$41.59b |
Gesamtvermögen | US$89.75b |
Jüngste Berichte zur Finanzlage
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Is Medtronic (NYSE:MDT) A Risky Investment?
Jun 21Recent updates
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05Medtronic: Is The Company Back?
Aug 26Medtronic: Still A Buy Before Earnings
Aug 17Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year
Jun 27Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Medtronic: Dark Clouds Are Clearing - Outperformance Ahead
Aug 14Return Trends At Medtronic (NYSE:MDT) Aren't Appealing
Aug 11Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth
Jul 15Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?
Jul 09Is Medtronic (NYSE:MDT) A Risky Investment?
Jun 21Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter
Jun 21Is Medtronic's Dividend In A Good Place?
Jun 14Analyse der Finanzlage
Kurzfristige Verbindlichkeiten: MDTDie kurzfristigen Aktiva des Unternehmens ($21.9B) übersteigen seine kurzfristigen Passiva ($10.8B).
Langfristige Verbindlichkeiten: MDTDie kurzfristigen Vermögenswerte des Unternehmens ($21.9B) decken seine langfristigen Verbindlichkeiten ($28.8B) nicht.
Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital
Verschuldungsgrad: MDTDie Nettoverschuldung im Verhältnis zum Eigenkapital (41.6%) wird als hoch angesehen.
Schulden abbauen: MDTDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 51.9% auf 57.9% gestiegen.
Schuldendeckung: MDTDie Schulden des Unternehmens sind gut durch den operativen Cashflow gedeckt (27.1%).
Zinsdeckung: MDTDie Zinszahlungen für die Schulden des Unternehmens sind durch das EBIT (9x Coverage) gut gedeckt.